Menu

ISTOCK, ART WAGER

Trump Nominates Scott Hutchins for USDA Top Scientist

A pesticide industry leader, Hutchins was formerly president of the Entomological Society of America.

Jul 18, 2018
Sukanya Charuchandra

President Donald Trump nominated Scott Hutchins, the global head of integrated field sciences for Corteva Agriscience,  the agriculture division of DowDuPont, to the role of undersecretary for research, education and economics at the US Department of Agriculture on Monday (July 16). Hutchins also serves as an adjunct professor at the University of Nebraska. 

The chief scientist position at the Department of Agriculture (USDA) has remained vacant since Trump took office. The previous nominee, Sam Clovis, the President’s campaign cochairman, pulled out of the running due to a number of controversies, according to Politico

If Hutchins is approved by the Senate, he will be the third individual with strong ties to Dow, which, in the past, has contributed to the President’s campaign fund, reports Mother Jones. His job will include planning the allocation of the USDA’s $2.9 billion budget. Hutchins has been with Dow Agrisciences, as it was known before it merged with DuPont, since earning his doctoral degree in 1987. Unlike Clovis, Hutchins has a scientific background, with his doctoral degree in entomology from Iowa State University, reports E&ENews. “His extensive background in research and commitment to sound science and data make him exceptionally qualified for this post, and I am eager to have Dr. Hutchins join the team,” Sonny Perdue, the Agriculture Secretary, says in a statement, according to E&ENews

Hutchins has been a former president for the Entomological Society of America, whose current president, Michael Parella of the University of Idaho, called Hutchins an “ideal candidate for the role,” in a statement released by the society, according to E&ENews.  

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.